Skip to main content
. 2020 Apr 7;2020(4):CD012309. doi: 10.1002/14651858.CD012309.pub2

CTRI/2013/02/003352.

Trial name or title Effect of a drug Mitomycin C in repair of tear ducts
Methods Randomized parallel‐group design
Participants Inclusion criteria: 90 adults aged 18 years and above with primary acquired nasolacrimal duct obstruction
Exclusion criteria: secondary causes like deviated nasal septum, nasal polyps, atrophic rhinitis, revision DCR/stents, renal failure or immunosuppression, pregnancy and lactation, out‐station patients, and patients not willing to consent
Interventions Intervention: mitomycin C
Comparison intervention: saline solution
Outcomes Primary outcome: success rates of EX‐DCR with and without intraoperative mitomycin C
Secondary outcome: none
Maximum follow‐up: 3 months
Starting date February 2013
Estimated end date: not reported
Contact information ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=5663&EncHid=&modid=&compid=%27,%275663det%27
Notes